GlassScriptPhysician profile
Dennis M Johnson
NPI 1871692905
$7,569.49
in general payments reported to CMS, 2019-2025
24 companies · $1,328 in 2025
The $1,328 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,949 · 2020: $348 · 2021: $853 · 2022: $1,162 · 2023: $633 · 2024: $1,296 · 2025: $1,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,033 · Consulting Fee: $725 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,032.54 |
| Consulting Fee | $725.08 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,781.60 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $1,244.44 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $1,040.20 | 2019-2025 | Precision 1, Hydrus Microstent, Total30 |
| Coopervision INC. | $622.66 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Allergan, INC. | $568.98 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $424.92 | 2022-2025 | Xiidra, Miebo, Infuse |
| Sun Pharmaceutical Industries INC. | $361.35 | 2021-2025 | Cequa |
| Biotissue Holdings INC. | $246.44 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $236.26 | 2019-2022 | |
| Carl Zeiss Meditec USA, INC. | $144.69 | 2022-2024 | Atlas Corneal Topography System, Cirrus Hd-Oct |
| Optovue, INC. | $138.93 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $122.52 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $102.44 | 2023-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Johnson & Johnson Surgical Vision, INC. | $101.48 | 2020 | |
| Optos, INC. | $72.75 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lombart Brothers, INC. | $59.58 | 2021-2023 | Opd-III |
| Sight Sciences, INC. | $57.92 | 2022 | |
| Abbvie INC. | $54.89 | 2023-2024 | |
| Apellis Pharmaceuticals, INC. | $46.36 | 2025 | Syfovre |
| Lkc Technologies, INC. | $34.14 | 2023 | |
| Aerie Pharmaceuticals, INC. | $32.02 | 2019-2020 | |
| Shire North American Group INC | $28.62 | 2019 | |
| Dompe US, INC. | $24.47 | 2021 | |
| Kala Pharmaceuticals, INC. | $21.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.